University of California, Los Angeles
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1919-05-23
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucla.edu
iCBT With TMS in Patients With MDD
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 40
- Registration Number
- NCT05988619
- Locations
- 🇺🇸
UCLA TMS Clinical and Research Service, Los Angeles, California, United States
UCLA Health Patient Health Maintenance Text Reminder July 2023
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 10000
- Registration Number
- NCT05979987
- Locations
- 🇺🇸
UCLA Health Department of Medicine, Quality Office, Los Angeles, California, United States
Remimazolam for Cataract Surgery
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 120
- Registration Number
- NCT05980117
- Locations
- 🇺🇸
Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles, California, United States
Open Trial of Biofeedback for Respiratory Symptoms
Recruiting
- Conditions
- First Posted Date
- 2023-08-03
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 25
- Registration Number
- NCT05973513
- Locations
- 🇺🇸
Natacha Emerson, Los Angeles, California, United States
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT05971758
An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT05956600
Endotypic Traits and Obstructive Sleep Apnea Surgery
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 150
- Registration Number
- NCT05953610
- Locations
- 🇺🇸
UCLA Santa Monica Medical Center, Santa Monica, California, United States
🇺🇸UCLA Westwood, Westwood, California, United States
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 150
- Registration Number
- NCT05949008
- Locations
- 🇺🇸
UCLA Center for Human Nutrition, Los Angeles, California, United States
Spinal Cord Stimulation to Shorten Ventilator Dependence in ARDS Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT05928052
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
PTSD Affect Labeling Study
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 119
- Registration Number
- NCT05924399
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath